These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34547339)

  • 1. Inhaled nano-based therapeutics for inflammatory lung diseases: Recent advances and future prospects.
    Gulati N; Chellappan DK; MacLoughlin R; Dua K; Dureja H
    Life Sci; 2021 Nov; 285():119969. PubMed ID: 34547339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges.
    Haque S; Whittaker MR; McIntosh MP; Pouton CW; Kaminskas LM
    Nanomedicine; 2016 Aug; 12(6):1703-24. PubMed ID: 27033834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects.
    Wan Q; Zhang X; Zhou D; Xie R; Cai Y; Zhang K; Sun X
    J Nanobiotechnology; 2023 Jul; 21(1):215. PubMed ID: 37422665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy.
    Jin Z; Gao Q; Wu K; Ouyang J; Guo W; Liang XJ
    Adv Drug Deliv Rev; 2023 Nov; 202():115111. PubMed ID: 37820982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled lipid nanocarriers for pulmonary delivery of glucocorticoids: Previous strategies, recent advances and key factors description.
    Altube MJ; Perez N; Romero EL; Morilla MJ; Higa LH; Perez AP
    Int J Pharm; 2023 Jul; 642():123146. PubMed ID: 37330156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery across the blood-brain barrier: recent advances in the use of nanocarriers.
    Mulvihill JJ; Cunnane EM; Ross AM; Duskey JT; Tosi G; Grabrucker AM
    Nanomedicine (Lond); 2020 Jan; 15(2):205-214. PubMed ID: 31916480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled chemotherapy in lung cancer: future concept of nanomedicine.
    Zarogoulidis P; Chatzaki E; Porpodis K; Domvri K; Hohenforst-Schmidt W; Goldberg EP; Karamanos N; Zarogoulidis K
    Int J Nanomedicine; 2012; 7():1551-72. PubMed ID: 22619512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicines via the pulmonary route: a promising strategy to reach the target?
    Guérin M; Lepeltier E
    Drug Deliv Transl Res; 2024 Aug; 14(8):2276-2297. PubMed ID: 38587757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological perspectives of inhaled therapeutics and nanoparticles.
    Hayes AJ; Bakand S
    Expert Opin Drug Metab Toxicol; 2014 Jul; 10(7):933-47. PubMed ID: 24810077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in nano-based drug delivery systems for the management of cytokine influx-mediated inflammation in lung diseases.
    Gulati N; Chellappan DK; MacLoughlin R; Gupta G; Singh SK; Oliver BG; Dua K; Dureja H
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):3695-3707. PubMed ID: 38078921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanomedicines for the treatment of glaucoma: Current status and future perspectives.
    Zhai Z; Cheng Y; Hong J
    Acta Biomater; 2021 Apr; 125():41-56. PubMed ID: 33601065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.
    Shen AM; Minko T
    J Control Release; 2020 Oct; 326():222-244. PubMed ID: 32681948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary delivery nanomedicines towards circumventing physiological barriers: Strategies and characterization approaches.
    Wang W; Huang Z; Huang Y; Zhang X; Huang J; Cui Y; Yue X; Ma C; Fu F; Wang W; Wu C; Pan X
    Adv Drug Deliv Rev; 2022 Jun; 185():114309. PubMed ID: 35469997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled nanoparticles--a current review.
    Yang W; Peters JI; Williams RO
    Int J Pharm; 2008 May; 356(1-2):239-47. PubMed ID: 18358652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine in pulmonary delivery.
    Mansour HM; Rhee YS; Wu X
    Int J Nanomedicine; 2009; 4():299-319. PubMed ID: 20054434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biokinetics of nanoparticles and susceptibility to particulate exposure in a murine model of cystic fibrosis.
    Geiser M; Stoeger T; Casaulta M; Chen S; Semmler-Behnke M; Bolle I; Takenaka S; Kreyling WG; Schulz H
    Part Fibre Toxicol; 2014 Apr; 11():19. PubMed ID: 24758489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future of nanomedicines for treating respiratory diseases.
    Scherließ R
    Expert Opin Drug Deliv; 2019 Jan; 16(1):59-68. PubMed ID: 30484722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnological Systems and Lung: A Perfect Combination for Lung Pharmaceutical Applications.
    Santonocito D; Puglia C
    Curr Med Chem; 2023; 30(6):725-743. PubMed ID: 36043745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.